刚果(金)南基伍省Xpert MTB/RIF利福平耐药不一致结果的回顾性队列分析
该研究回顾性分析2013—2018年南基伍省1900份MTB阳性Xpert存档文件,以MTBDRplus为参考,发现141份双检样本中45份(31.9%)Xpert提示利福平耐药而MTBDRplus敏感,低和极低菌量与之相关。
要点
- Xpert提示利福平耐药而MTBDRplus敏感的不一致率为31.9%(45/141)。
- 极低菌量(Ct>28)和低菌量(Ct 22-28)与不一致结果相关。
- 探针E最常缺失,其次为多探针缺失或探针未结合。
核心结论
- 痰标本中MTB低和极低菌量与Xpert利福平耐药不一致结果强相关。
研究设计与样本
- 回顾性横断面分析,纳入2013—2018年南基伍省用于诊断MTB的存档Xpert文件。
- 以覆盖同一81-bp RRDR的MTBDRplus线性探针 assay 作为参考试验。
- 1900份MTB阳性样本中220份(11.2%)为利福平耐药,141份有Xpert和MTBDRplus双结果。
主要发现
- 141份双检痰样本中45份(31.9%)结果不一致,Xpert提示利福平耐药而MTBDRplus提示敏感。
- 极低菌量(Ct>28)与不一致结果相关,OR=2.23,95% CI: 1.30-3.82。
- 低菌量(Ct 22-28)与不一致结果相关,OR=1.81,95% CI: 1.21-2.71。
- 探针E最常缺失,其次为多探针缺失或探针未结合,OR=1.5,95% CI: .731-3.076。
临床怎么用
- 对Xpert提示利福平耐药但菌量低或极低的痰标本,应警惕假阳性可能。
- 可结合MTBDRplus等参考方法复核Xpert利福平耐药不一致结果。
局限性
- 为回顾性分析,需进一步研究阐明潜在机制以确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Xpert assay has revolutionized the rapid detection of resistance to rifampicin. However, Xpert has its pitfalls. We explored potential determinants of false-positive rifampicin resistance when using Xpert, aiming to refine the precision of tuberculosis diagnostics and subsequently contribute to better patient outcomes. METHODS: This is a retrospective cross-sectional analysis of archived Xpert files from the South Kivu province, used to diagnose Mycobacterium tuberculosis (MTB) between 2013 and 2018. Xpert cycle threshold was extracted for each molecular beacon probe, and ΔCt was calculated. We used the MTBDRplus line-probe assay, which covers the same 81-bp RRDR, as a reference test. RESULTS: Of 1900 samples positive for MTB, 220 (11.2%) were rifampicin resistant. Of the 141 patients' sputum samples that had results for both Xpert and MTBDRplus, 45 (31.9%) showed discordant results with Xpert, indicating rifampicin resistance while MTBDRplus indicated rifampicin susceptibility, suggesting false-positive rifampicin resistance detection by Xpert, predominantly in samples with very low (Ct > 28, odds ratio [OR] = 2.23, 95% CI: 1.30-3.82) or low (Ct 22-28, OR = 1.81, 95% CI: 1.21-2.71) bacterial loads. Probe E was the most frequently missed probe, followed by multiple probe dropouts or absence of probe binding (OR = 1.5, 95% CI: .731-3.076). CONCLUSIONS: Our findings indicate that low and very low MTB bacterial loads in sputum are strongly associated with discordant rifampicin resistance results when using Xpert. Further research into underlying mechanisms is needed to establish causality definitively.
引用
- Bisimwa BC, Kiselinova M, Cuella-Martin I, et al. Retrospective Cohort Analysis for Identification of Discordant Rifampicin-resistant Xpert MTB/RIF Assay Results in South Kivu, Eastern Democratic Republic of the Congo, a High Burden Tuberculosis Setting. Clin Infect Dis. 2026. PMID: 40796199. doi:10.1093/cid/ciaf451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。